Till startsida
To content Read more about how we use cookies on gu.se

Michael Ashton


Michael Ashton
+46 31 786 3412

Postal Address: Box 431, 40530 Göteborg
Visiting Address: Medicinaregatan 13 , 41390 Göteborg

Department of Pharmacolgy at Institute of Neuroscience and Physiology (More Information)
Box 431
405 30 Göteborg
Fax: +46 31821795
Visiting Address: Medicinaregatan 11-13 , 413 90 Göteborg

About Michael Ashton

Latest publications

Simultaneous quantification of four first line antitubercular drugs and metabolites in human plasma by hydrophilic interaction chromatography and tandem mass spectrometry
Jesper Sundell, E. Bienvenu, Sofia Birgersson, Angela Äbelö, Michael Ashton et al.
Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Journal article 2019
Journal article

Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis
F. Kloprogge, L. Workman, S. Borrmann, M. Tekete, G. Lefevre et al.
Plos Medicine, Journal article 2018
Journal article

MRP2/ABCC2 C1515Y polymorphism modulates exposure to lumefantrine during artemether-lumefantrine antimalarial therapy
K. Vos, C. Lo Sciuto, R. Piedade, Michael Ashton, A. Bjorkman et al.
Pharmacogenomics, Journal article 2017
Journal article

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications
Richard Höglund, Pauline Byakika‐Kibwika, Mohammed Lamorde, Concepta Merry, Michael Ashton et al.
British Journal of Clinical Pharmacology, Journal article 2015
Journal article

Population pharmacokinetics of artesunate and dihydroartemisinin during long-term oral administration of artesunate to patients with metastatic breast cancer.
Therese Ericsson, Antje Blank, Cornelia von Hagens, Michael Ashton, Angela Abelö
European Journal of Clinical Pharmacology, Journal article 2014
Journal article

Showing 21 - 30 of 60


Mono-, di- and trisubstituted derivatives of eflornithine: synthesis for in vivo delivery of DL-alpha-difluoromethylornithine in plasma
TT Cloete, Carl C. Johansson, DD N'Da, SK Vodnala, ME Rottenberg et al.
Arzneimittelforschung Drug Research, Journal article 2011
Journal article

HIV/AIDS Patients Display Lower Relative Bioavailability of Efavirenz than Healthy Subjects.
Jackson K Mukonzo, Sarah Nanzigu, Dinko Rekić, Paul Waako, Daniel Röshammar et al.
Clinical pharmacokinetics, Journal article 2011
Journal article

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.
Dinko Rekić, Oskar Clewe, Daniel Röshammar, Leo Flamholc, Anders Sönnerborg et al.
The AAPS journal, Journal article 2011
Journal article

Orally formulated artemisinin in healthy fasting vietnamese male subjects: a randomized, four-sequence, open-label, pharmacokinetic crossover study.
Tran Tinh Hien, Warunee Hanpithakpong, Nguyen Thanh Truong, Nguyen Thi Dung, Pham Van Toi et al.
Clinical therapeutics, Journal article 2011
Journal article


Effects of oral administration of synthesized delta-amides of eflornithine in the rat
Kevin J. Helena, David D. N''Da, Carl C. Johansson, Jaco C. Breytenbach, Michael Ashton
Journal article

Population pharmacokinetics and pharmacodynamics of artemether and lumefantrine during combination treatment in children with uncomplicated falciparum malaria in Tanzania
Sofia Friberg Hietala, Andreas Mårtensson, Billy Ngasala, Sabina Dahlström, Niklas Lindegårdh et al.
Antimicrobial agents and chemotherapy, Journal article 2010
Journal article


Artemisinin--a possible CYP2B6 probe substrate?
Sara Asimus, Michael Ashton
Biopharmaceutics & drug disposition, Journal article 2009
Journal article

Quantification of artemisinin in human plasma using liquid chromatography coupled to tandem mass spectrometry.
N Lindegardh, J Tarning, P V Toi, T T Hien, J Farrar et al.
Journal of pharmaceutical and biomedical analysis, Journal article 2009
Journal article

Showing 21 - 30 of 60

Page Manager: Webbredaktör|Last update: 1/12/2017

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?